Classification of Breast Masses Using SAVE Method

Overview

Información sobre este estudio

The purpose of this research is to evaluate the efficacy of a new breast tissue assessment tool that provides new diagnostic information about breast masses and potential for early classification of malignant masses.

This study is being done to:

• Test an investigational breast imaging system;

• Image the breast and see if we can differentiate lesions by using the investigational imaging system;

• Test an investigational breast stiffness measurement method

• Test and compare to an FDA approved ultrasound stiffness imaging system (GE LOGIQ E9 (LE9)

• Compare to ultrasound images using Alpinion clinical ultrasound platform, FDA approved ECUBE 12 and a non-FDA approved ECUBE 12R

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

Females in age range between 18 and up who have a breast lesion that may or may not be suspicious for breast cancer, and are referred for Radiological investigation. It is anticipated that the majority of these participants will undergo a biopsy (standard of care). The SAVE data collection from each participant will take place before biopsy or at least 2 weeks post biopsy.

 

Exclusion Criteria: 

No history of mastectomy or implants, or having any condition that does not allow proper use of our imaging devices. Since we are using B-mode images to guide the SAVE data acquisition, we only include patients with masses detectable under ultrasound.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Azra Alizad, M.D.

Cerrado para la inscripción

Contact information:

Azra Alizad M.D.

(507) 538-1727

Alizad.Azra@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20313599

Mayo Clinic Footer